Correction to: A placebo ‑controlled, double‑blind, randomized study of recombinant thrombomodulin (ART‑123) to prevent oxaliplatin‑induced peripheral neuropathy
In the Original publication of the article, the authors found an error in the “Results” section under the heading “Abstract”. The corrected text is given below.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Eyes | Neurology | Peripheral Neuropathy | Study